BioLife Plasma Services L.P.

FDA inspection history on file, 2026

1
Form 483

Every document, by year

  • Form 483

2026: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2026One Form 483.

Cited most

Across all BioLife Plasma Services observations on file

  • 21 CFR 606.100
    Standard operating procedures
    1
  • 21 CFR 630.10
    General donor eligibility requirements
    1
  • 21 CFR 630.30
    Donation suitability requirements
    1
  • 21 CFR 630.40
    Requirements for notifying deferred donors
    1
  • 21 CFR 630.5
    Medical supervision
    1

The complete BioLife Plasma Services file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Documents

1 on file, newest first
DateDocumentPrice
2026-03-20483 Form 483$99

Investigators on these documents

Shelley H. Beausoleil (1)

FEI number 3023831018 · most recent document Mar 20, 2026

About BioLife Plasma Services L.P.

How many FDA Form 483s has BioLife Plasma Services L.P. received?

FDA Intel has 1 Form 483 on file for BioLife Plasma Services L.P.; the most recent is dated Mar 20, 2026.

When was BioLife Plasma Services L.P. last inspected by FDA?

The most recent FDA inspection document on file for BioLife Plasma Services L.P. is a Form 483 dated Mar 20, 2026.

What did FDA cite at BioLife Plasma Services L.P.?

The regulations cited most in the observations on file for BioLife Plasma Services L.P. are 21 CFR 606.100 (Standard operating procedures), 1 time; 21 CFR 630.10 (General donor eligibility requirements), 1 time; 21 CFR 630.30 (Donation suitability requirements), 1 time.